313 related articles for article (PubMed ID: 15108287)
1. A novel splice-site mutation in the common gamma chain (gammac) gene IL2RG results in X-linked severe combined immunodeficiency with an atypical NK+ phenotype.
Ginn SL; Smyth C; Wong M; Bennetts B; Rowe PB; Alexander IE
Hum Mutat; 2004 May; 23(5):522-3. PubMed ID: 15108287
[TBL] [Abstract][Full Text] [Related]
2. Defective IL7R expression in T(-)B(+)NK(+) severe combined immunodeficiency.
Puel A; Ziegler SF; Buckley RH; Leonard WJ
Nat Genet; 1998 Dec; 20(4):394-7. PubMed ID: 9843216
[TBL] [Abstract][Full Text] [Related]
3. Mutation analysis should be performed to rule out gammac deficiency in children with functional severe combined immune deficiency despite apparently normal immunologic tests.
Somech R; Roifman CM
J Pediatr; 2005 Oct; 147(4):555-7. PubMed ID: 16227049
[TBL] [Abstract][Full Text] [Related]
4. Patients with T⁺/low NK⁺ IL-2 receptor γ chain deficiency have differentially-impaired cytokine signaling resulting in severe combined immunodeficiency.
Fuchs S; Rensing-Ehl A; Erlacher M; Vraetz T; Hartjes L; Janda A; Rizzi M; Lorenz MR; Gilmour K; de Saint-Basile G; Roifman CM; Cheuk S; Gennery A; Thrasher AJ; Fuchs I; Schwarz K; Speckmann C; Ehl S
Eur J Immunol; 2014 Oct; 44(10):3129-40. PubMed ID: 25042067
[TBL] [Abstract][Full Text] [Related]
5. Female germ line mosaicism as the origin of a unique IL-2 receptor gamma-chain mutation causing X-linked severe combined immunodeficiency.
Puck JM; Pepper AE; Bédard PM; Laframboise R
J Clin Invest; 1995 Feb; 95(2):895-9. PubMed ID: 7860773
[TBL] [Abstract][Full Text] [Related]
6. Selective growth advantage of wild-type lymphocytes in X-linked SCID recipients.
Kume A; Koremoto M; Mizukami H; Okada T; Hanazono Y; Sugamura K; Ozawa K
Bone Marrow Transplant; 2002 Jul; 30(2):113-8. PubMed ID: 12132050
[TBL] [Abstract][Full Text] [Related]
7. Phage phiC31 integrase-mediated genomic integration of the common cytokine receptor gamma chain in human T-cell lines.
Ishikawa Y; Tanaka N; Murakami K; Uchiyama T; Kumaki S; Tsuchiya S; Kugoh H; Oshimura M; Calos MP; Sugamura K
J Gene Med; 2006 May; 8(5):646-53. PubMed ID: 16508910
[TBL] [Abstract][Full Text] [Related]
8. Efficient detection of thirty-seven new IL2RG mutations in human X-linked severe combined immunodeficiency.
Niemela JE; Puck JM; Fischer RE; Fleisher TA; Hsu AP
Clin Immunol; 2000 Apr; 95(1 Pt 1):33-8. PubMed ID: 10794430
[TBL] [Abstract][Full Text] [Related]
9. X-linked SCID and other defects of cytokine pathways.
Uribe L; Weinberg KI
Semin Hematol; 1998 Oct; 35(4):299-309. PubMed ID: 9801259
[TBL] [Abstract][Full Text] [Related]
10. Structure of the quaternary complex of interleukin-2 with its alpha, beta, and gammac receptors.
Wang X; Rickert M; Garcia KC
Science; 2005 Nov; 310(5751):1159-63. PubMed ID: 16293754
[TBL] [Abstract][Full Text] [Related]
11. Impaired IL-7 signaling may explain a case of atypical JAK3-SCID.
Li J; Nara H; Rahman M; Juliana FM; Araki A; Asao H
Cytokine; 2010 Feb; 49(2):221-8. PubMed ID: 19889552
[TBL] [Abstract][Full Text] [Related]
12. Interleukin-2 (IL-2) receptor gamma chain mutations in X-linked severe combined immunodeficiency disease result in the loss of high-affinity IL-2 receptor binding.
DiSanto JP; Dautry-Varsat A; Certain S; Fischer A; de Saint Basile G
Eur J Immunol; 1994 Feb; 24(2):475-9. PubMed ID: 8299698
[TBL] [Abstract][Full Text] [Related]
13. Sustained correction of X-linked severe combined immunodeficiency by ex vivo gene therapy.
Hacein-Bey-Abina S; Le Deist F; Carlier F; Bouneaud C; Hue C; De Villartay JP; Thrasher AJ; Wulffraat N; Sorensen R; Dupuis-Girod S; Fischer A; Davies EG; Kuis W; Leiva L; Cavazzana-Calvo M
N Engl J Med; 2002 Apr; 346(16):1185-93. PubMed ID: 11961146
[TBL] [Abstract][Full Text] [Related]
14. Skin infiltration of CD56(bright) CD16(-) natural killer cells in a case of X-SCID with Omenn syndrome-like manifestations.
Shibata F; Toma T; Wada T; Inoue M; Tone Y; Ohta K; Kasahara Y; Sano F; Kimura M; Ikeno M; Koizumi S; Yachie A
Eur J Haematol; 2007 Jul; 79(1):81-5. PubMed ID: 17598841
[TBL] [Abstract][Full Text] [Related]
15. Alport syndrome. Molecular genetic aspects.
Hertz JM
Dan Med Bull; 2009 Aug; 56(3):105-52. PubMed ID: 19728970
[TBL] [Abstract][Full Text] [Related]
16. A synonymous splice site mutation in IL2RG gene causes late-onset combined immunodeficiency.
Yamashita M; Wakatsuki R; Kato T; Okano T; Yamanishi S; Mayumi N; Tanaka M; Ogura Y; Kanegane H; Nonoyama S; Imai K; Morio T
Int J Hematol; 2019 May; 109(5):603-611. PubMed ID: 30850927
[TBL] [Abstract][Full Text] [Related]
17. Detection of a novel nonsense mutation in the interleukin 2 receptor gamma gene causing X-linked severe combined immunodeficiency.
Cohen L; Hirschfeld AF; Junker AK; Davis J; Turvey SE
Ann Allergy Asthma Immunol; 2006 Apr; 96(4):632. PubMed ID: 16680939
[No Abstract] [Full Text] [Related]
18. Interleukin 7 receptor alpha-chain-mutation severe combined immunodeficiency without lymphopenia: correction with haploidentical T-cell-depleted bone marrow transplantation.
Ponda P; Schuval SJ; Kaplan B; Logalbo P; Roberts JL; Bonagura VR
Ann Allergy Asthma Immunol; 2006 Dec; 97(6):755-8. PubMed ID: 17201233
[TBL] [Abstract][Full Text] [Related]
19. Lymphoid development and function in X-linked severe combined immunodeficiency mice after stem cell gene therapy.
Otsu M; Anderson SM; Bodine DM; Puck JM; O'Shea JJ; Candotti F
Mol Ther; 2000 Feb; 1(2):145-53. PubMed ID: 10933924
[TBL] [Abstract][Full Text] [Related]
20. T
Stepensky P; Keller B; Shamriz O; von Spee-Mayer C; Friedmann D; Shadur B; Unger S; Fuchs S; NaserEddin A; Rumman N; Amro S; Molho Pessach V; Abuzaitoun O; Somech R; Elpeleg O; Ehl S; Warnatz K
J Clin Immunol; 2018 May; 38(4):527-536. PubMed ID: 29948574
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
